- Celiac Disease Research: Associated Diseases and Disorders
- Eye Problems, Cataract and Celiac Disease
- Higher Cataract Risk for People with Celiac Disease
Higher Cataract Risk for People with Celiac Disease
Jefferson Adams is a freelance writer living in San Francisco. His poems, essays and photographs have appeared in Antioch Review, Blue Mesa Review, CALIBAN, Hayden's Ferry Review, Huffington Post, the Mississippi Review, and Slate among others.
He is a member of both the National Writers Union, the International Federation of Journalists, and covers San Francisco Health News for Examiner.com.View all articles by Jefferson Adams
New research on cataract risk and celiac disease.
The population-based cohort study was undertaken in order to to determine the risk of cataract among persons with biopsy-verified celiac disease. The research team included Kaziwe Mollazadegan, Maria Kugelberg, Birgitta Ejdervik Lindblad and Jonas F. Ludvigsson.
For the study, they collected data on celiac disease from reports on small intestinal biopsies performed between July 1969 and February 2008 in the 28 regional pathology departments in Sweden. They then compared those results to data from up to five age- and sex-matched controls for each patient. The team then used Cox regression analysis to estimate cataract risk.
They found 28,756 persons with clinically celiac disease, that is, with confirmed Marsh pathology stage 3 villous atrophy.
For the average follow-up period of about ten years, the researchers found 1,159 cases of cataracts among people with celiac disease, compared with an projection of 909 cases, based on the general population. With a hazard ratio of 1.28, 95% confidence interval: 1.19, 1.36. The team found that the absolute risk of cataract was 397/100,000 person-years for those with celiac disease, with an excess risk of 86/100,000 person-years.
This study confirms that people with celiac disease face a slightly increased risk of developing cataracts, compared with the general population.
As always, Celiac.com welcomes your comments (see below).